. . . . . "Olanzapine" . . . "agitation" . . . . . . "The purpose of this review is to summarize the current evidence of the off-label use of intravenous (IV) olanzapine and discuss its risks versus benefits for the management of agitation." . . . . . . . "Adults" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" . "DEcUwGxZkZePqNUM1P5QDQBrtM/C1+F6UTx0M8KNwNWN44YOku+CuAyEAnrhz54xCZ2AOQfget4cEOWp4zHngoY8LEyFeWoyS4GI2ghPq+76BnxPAZnItZT7stO1/CeQU0i5Q7BTKU1WJWRmfsxHghaIxmBagtHYop5QTCyjfms=" . . "2022-09-16T11:51:40.027944"^^ . . . "2.3.0" .